Research Paper Volume 16, Issue 2 pp 1879—1896
CDK16 as a potential prognostic biomarker correlated with an immunosuppressive tumor microenvironment and benefits in enhancing the effectiveness of immunotherapy in human cancers
Figure 10. Relationship of CDK16 expression and tumor mutational burden (TMB), microsatellite instability (MSI). (A) Radar map illustrating the relationship between CDK16 expression and TMB. (B) Radar map illustrating the relationship between CDK16 expression and MSI. The red lines represent correlation coefficients, and blue values represent ranges. Spearman correlation test, *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.